Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

3.7K
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
3.7K
Cancer Vaccines01:30

Cancer Vaccines

625
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
625
Cancer Survival Analysis01:21

Cancer Survival Analysis

525
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
525
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

4.1K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.1K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

5.8K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Landscape of Prostate Tumour Methylation.

Cancer discovery·2026
Same author

Stage-Specific Regulation of DNA Damage Repair by the Circadian Regulator, CRY1, in Prostate Cancer.

bioRxiv : the preprint server for biology·2026
Same author

Single-cell and spatial RNA sequencing in prostate cancer.

Nature reviews. Urology·2026
Same author

Exploring DNA Damage Repair Therapeutics in Prostate Cancer beyond BRCAness.

Molecular cancer therapeutics·2026
Same author

PARP inhibition and pharmacological ascorbate demonstrate synergy in castration-resistant prostate cancer.

Molecular oncology·2026
Same author

Clonal evolution and transcriptional plasticity shape metastatic dissemination routes in prostate cancer.

Nature communications·2025
Same journal

Accidental hypothermia.

Nature reviews. Disease primers·2026
Same journal

Accidental hypothermia.

Nature reviews. Disease primers·2026
Same journal

Primary aldosteronism.

Nature reviews. Disease primers·2026
Same journal

Primary aldosteronism.

Nature reviews. Disease primers·2026
Same journal

Buruli ulcer in Africa: between innovation and pragmatism.

Nature reviews. Disease primers·2026
Same journal

Author Correction: Atopic dermatitis.

Nature reviews. Disease primers·2026
See all related articles

Related Experiment Video

Updated: Nov 18, 2025

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

13.5K

Prostate cancer.

Richard J Rebello1, Christoph Oing1,2, Karen E Knudsen3

  • 1Cancer Research UK Manchester Institute, University of Manchester, Manchester Cancer Research Centre, Manchester, UK.

Nature Reviews. Disease Primers
|February 5, 2021
PubMed
Summary
This summary is machine-generated.

Early detection and treatment of prostate cancer offer a 99% survival rate for localized disease. Research focuses on understanding genetic alterations and improving detection, management, and outcomes for this common male cancer.

More Related Videos

miRNA Expression Analyses in Prostate Cancer Clinical Tissues
11:29

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

11.0K
Pre-clinical Orthotopic Murine Model of Human Prostate Cancer
07:01

Pre-clinical Orthotopic Murine Model of Human Prostate Cancer

Published on: August 29, 2016

14.7K

Related Experiment Videos

Last Updated: Nov 18, 2025

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

13.5K
miRNA Expression Analyses in Prostate Cancer Clinical Tissues
11:29

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

11.0K
Pre-clinical Orthotopic Murine Model of Human Prostate Cancer
07:01

Pre-clinical Orthotopic Murine Model of Human Prostate Cancer

Published on: August 29, 2016

14.7K

Area of Science:

  • Oncology
  • Genetics
  • Urology

Background:

  • Prostate cancer is a significant global health concern, particularly in developed nations.
  • Early-stage localized prostate cancer often has a favorable prognosis with high survival rates.
  • Key genetic factors like TMPRSS2-ETS fusions, MYC amplification, and PTEN/TP53 alterations are implicated.

Purpose of the Study:

  • To provide an overview of prostate cancer, including its genetic landscape.
  • To outline current diagnostic and treatment strategies for localized and advanced disease.
  • To highlight ongoing research directions for improving patient outcomes.

Main Methods:

  • Review of current literature on prostate cancer biology, diagnosis, and treatment.
  • Analysis of genetic alterations associated with different disease stages.
  • Summary of therapeutic approaches for localized, relapsed, and advanced prostate cancer.

Main Results:

  • Early detection and treatment yield excellent survival rates (99% at 10 years) for localized prostate cancer.
  • Various genetic alterations are associated with prostate cancer development and progression.
  • Treatment options range from active surveillance and surgery to radiotherapy, hormone therapy, chemotherapy, and targeted agents.

Conclusions:

  • Prostate cancer management requires a multi-faceted approach considering disease stage and genetic profile.
  • Advanced prostate cancer, particularly castration-resistant forms, presents significant treatment challenges.
  • Continued research into prostate cancer's fundamental biology is crucial for advancing detection, treatment, and patient survival.